Q1 2025 · 13F-HR
ADAR1 Capital Management, LLCholdings as filed
Filed 2025-05-15 · accession 0001940272-25-000003
$538.7M
Reported value
202
Positions
2025-03-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 74366E102 | PTGX | PROTAGONIST THERAPEUTICS INC | $45.4M | 8.44% | 939,669 | Common | SOLE |
| 02072L565 | BOXX | EA SERIES TRUST | $37.6M | 6.98% | 337,125 | Common | SOLE |
| G76279101 | ROIV | ROIVANT SCIENCES LTD | $35.1M | 6.52% | 3,483,404 | Common | SOLE |
| 98887Q104 | ZLAB | ZAI LAB LTD | $34.0M | 6.31% | 940,858 | Common | SOLE |
| 45258J102 | IMVT | IMMUNOVANT INC | $16.6M | 3.07% | 968,866 | Common | SOLE |
| 23282W605 | CYTK | CYTOKINETICS INC | $15.7M | 2.92% | 390,729 | Common | SOLE |
| 492327101 | KROS | KEROS THERAPEUTICS INC | $15.1M | 2.81% | 1,486,461 | Common | SOLE |
| 00370M103 | ABVX | ABIVAX SA | $13.8M | 2.56% | 2,210,019 | Common | SOLE |
| 78468R663 | BIL | SPDR SER TR | $12.4M | 2.31% | 135,585 | Common | SOLE |
| 10806X102 | BBIO | BRIDGEBIO PHARMA INC | $11.7M | 2.18% | 339,635 | Common | SOLE |
| 45719W205 | IKT | INHIBIKASE THERAPEUTICS INC | $11.2M | 2.08% | 5,122,105 | Common | SOLE |
| 85205L107 | SWTXUSD | SPRINGWORKS THERAPEUTICS INC | $9.2M | 1.70% | 207,778 | Common | SOLE |
| 464287457 | SHY | ISHARES TR | $8.5M | 1.59% | 103,337 | Common | SOLE |
| 881624209 | TEVA | TEVA PHARMACEUTICAL INDS LTD | $8.1M | 1.49% | 523,767 | Common | SOLE |
| 803607100 | SRPT | SAREPTA THERAPEUTICS INC | $7.8M | 1.46% | 122,921 | Common | SOLE |
| G70077105 | PCSC | PERCEPTIVE CAP SOLUTIONS COR | $7.7M | 1.43% | 750,000 | Common | SOLE |
| 156944100 | CGON | CG ONCOLOGY INC | $7.4M | 1.37% | 301,134 | Common | SOLE |
| 75382E109 | — | RAPT THERAPEUTICS INC | $7.3M | 1.35% | 5,970,768 | Common | SOLE |
| 47103J105 | JANX | JANUX THERAPEUTICS INC | $7.2M | 1.33% | 264,900 | CALL | SOLE |
| 03879J100 | ABUS | ARBUTUS BIOPHARMA CORP | $6.6M | 1.22% | 1,879,114 | Common | SOLE |
| 46116X101 | ITCIEUR | INTRA-CELLULAR THERAPIES INC | $6.3M | 1.18% | 48,044 | Common | SOLE |
| 76155X100 | RVMD | REVOLUTION MEDICINES INC | $6.3M | 1.16% | 177,136 | Common | SOLE |
| 03675P102 | AVR | ANTERIS TECHNOLOGIES GLOBAL | $6.1M | 1.13% | 1,678,063 | Common | SOLE |
| G1000R101 | AAM | AA MISSION ACQUISITION CORP | $6.0M | 1.12% | 578,359 | Common | SOLE |
| 78667J108 | SG7 | SAGE THERAPEUTICS INC | $5.9M | 1.10% | 742,495 | Common | SOLE |
| 282559103 | ETNBGBP | 89BIO INC | $5.8M | 1.09% | 804,220 | Common | SOLE |
| 66987V109 | NVS | NOVARTIS AG | $5.6M | 1.03% | 50,000 | PUT | SOLE |
| 19249HAB9 | — | COHERUS BIOSCIENCES INC | $5.5M | 1.02% | 5,625,000 | Common | SOLE |
| G6717R120 | OACCU | OAKTREE ACQUISITION CORP III | $5.4M | 1.00% | 516,482 | Common | SOLE |
| G4444H101 | BBOT | HELIX ACQUISITION CORP II | $5.3M | 0.99% | 469,729 | Common | SOLE |
| 03237H101 | AMLX | AMYLYX PHARMACEUTICALS INC | $5.2M | 0.97% | 1,471,587 | Common | SOLE |
| 80706P103 | SRRK | SCHOLAR ROCK HLDG CORP | $5.1M | 0.94% | 157,079 | Common | SOLE |
| 98420N105 | XENE | XENON PHARMACEUTICALS INC | $4.3M | 0.79% | 127,548 | Common | SOLE |
| 98401F105 | XNCR | XENCOR INC | $4.2M | 0.79% | 398,152 | Common | SOLE |
| 603170101 | MLYS | MINERALYS THERAPEUTICS INC | $4.2M | 0.78% | 263,425 | Common | SOLE |
| 81734D104 | SEPN | SEPTERNA INC | $4.2M | 0.77% | 720,848 | Common | SOLE |
| 47103J105 | JANX | JANUX THERAPEUTICS INC | $4.2M | 0.77% | 153,767 | Common | SOLE |
| 10806XAD4 | BBIO 2.25 02/01/29 | BRIDGEBIO PHARMA INC | $4.0M | 0.75% | 4,500,000 | Common | SOLE |
| 03770N101 | APGE | APOGEE THERAPEUTICS INC | $3.9M | 0.73% | 104,853 | Common | SOLE |
| 805111101 | SVRA | SAVARA INC | $3.8M | 0.70% | 1,360,291 | Common | SOLE |
| 61023L207 | MNPR | MONOPAR THERAPEUTICS INC | $3.7M | 0.68% | 100,774 | Common | SOLE |
| 008064107 | — | AEROVATE THERAPEUTICS INC | $3.7M | 0.68% | 1,461,234 | Common | SOLE |
| 09077V100 | BIOA | BIOAGE LABS INC | $3.7M | 0.68% | 971,100 | Common | SOLE |
| G9TY5A101 | ZURA | ZURA BIO LTD | $3.6M | 0.67% | 2,801,184 | Common | SOLE |
| 834203309 | SLNO | SOLENO THERAPEUTICS INC | $3.6M | 0.66% | 50,000 | PUT | SOLE |
| 04635X102 | CATBUSD | ASTRIA THERAPEUTICS INC | $3.4M | 0.64% | 641,690 | Common | SOLE |
| 76200L309 | RZLT | REZOLUTE INC | $3.2M | 0.60% | 1,116,047 | Common | SOLE |
| 152309100 | CNTA | CENTESSA PHARMACEUTICALS PLC | $3.1M | 0.58% | 216,166 | Common | SOLE |
| 00973Y108 | AKRO | AKERO THERAPEUTICS INC | $2.9M | 0.53% | 71,143 | Common | SOLE |
| N5749R100 | 2GH | MERUS N V | $2.8M | 0.52% | 66,960 | Common | SOLE |
| 10806XAH5 | — | BRIDGEBIO PHARMA INC | $2.7M | 0.51% | 2,666,627 | Common | SOLE |
| 69366J200 | PTCT | PTC THERAPEUTICS INC | $2.5M | 0.47% | 50,023 | Common | SOLE |
| 75901B107 | RGNX | REGENXBIO INC | $2.5M | 0.47% | 350,352 | Common | SOLE |
| 039697107 | ARDX | ARDELYX INC | $2.4M | 0.45% | 490,743 | Common | SOLE |
| 10806XAB8 | BBIO 2.5 03/15/27 | BRIDGEBIO PHARMA INC | $2.3M | 0.42% | 2,000,000 | Common | SOLE |
| 268158201 | DVAX | DYNAVAX TECHNOLOGIES CORP | $2.2M | 0.41% | 170,000 | Common | SOLE |
| 04335A105 | ARVN | ARVINAS INC | $2.2M | 0.41% | 313,354 | Common | SOLE |
| G0544A103 | ASPC | A SPAC III ACQUISITION CORP | $2.2M | 0.40% | 215,000 | Common | SOLE |
| 76243J105 | RYTM | RHYTHM PHARMACEUTICALS INC | $2.0M | 0.36% | 36,890 | Common | SOLE |
| 86627T108 | SMMT | SUMMIT THERAPEUTICS INC | $1.9M | 0.36% | 100,000 | CALL | SOLE |
| 24661P807 | DCTH | DELCATH SYS INC | $1.9M | 0.35% | 149,385 | Common | SOLE |
| 22663K107 | CRNX | CRINETICS PHARMACEUTICALS IN | $1.8M | 0.33% | 53,125 | Common | SOLE |
| 483119202 | KALAEUR | KALA BIO INC | $1.7M | 0.32% | 298,955 | Common | SOLE |
| 92764N102 | VIR | VIR BIOTECHNOLOGY INC | $1.6M | 0.30% | 250,000 | Common | SOLE |
| 77313F106 | RCKT | ROCKET PHARMACEUTICALS INC | $1.6M | 0.30% | 241,800 | Common | SOLE |
| 877619106 | TSHA | TAYSHA GENE THERAPIES INC | $1.5M | 0.28% | 1,066,309 | Common | SOLE |
| 92686J106 | VKTX | VIKING THERAPEUTICS INC | $1.4M | 0.27% | 59,413 | Common | SOLE |
| 359616109 | FULC | FULCRUM THERAPEUTICS INC | $1.4M | 0.26% | 490,532 | Common | SOLE |
| 14179K101 | CRGX | CARGO THERAPEUTICS INC | $1.4M | 0.26% | 341,515 | Common | SOLE |
| 687604108 | ORKA | ORUKA THERAPEUTICS INC | $1.4M | 0.25% | 132,780 | Common | SOLE |
| 834203309 | SLNO | SOLENO THERAPEUTICS INC | $1.3M | 0.25% | 18,830 | Common | SOLE |
| 925050106 | VRNA | VERONA PHARMA PLC | $1.3M | 0.24% | 20,000 | Common | SOLE |
| 162828206 | — | CHECKPOINT THERAPEUTICS INC | $1.2M | 0.23% | 305,800 | Common | SOLE |
| 01438T106 | ALDX | ALDEYRA THERAPEUTICS INC | $1.2M | 0.23% | 211,579 | Common | SOLE |
| 500946108 | KRRO | KORRO BIO INC | $1.2M | 0.22% | 68,715 | Common | SOLE |
| 21217B100 | CTNM | CONTINEUM THERAPEUTICS INC | $1.2M | 0.22% | 168,765 | Common | SOLE |
| 878972108 | TECX | TECTONIC THERAPEUTIC INC | $1.1M | 0.21% | 62,603 | Common | SOLE |
| 92790C104 | VRDN | VIRIDIAN THERAPEUTICS INC | $1.1M | 0.20% | 79,000 | Common | SOLE |
| 92840H400 | VTGN | VISTAGEN THERAPEUTICS INC | $1.1M | 0.20% | 420,765 | Common | SOLE |
| 717081103 | PFE | PFIZER INC | $1.0M | 0.19% | 41,050 | Common | SOLE |
| G33033104 | KDK | ARES ACQUISITION CORP II | $1.0M | 0.19% | 90,466 | Common | SOLE |
| 86881A100 | SGRY | SURGERY PARTNERS INC | $950,000 | 0.18% | 40,000 | Common | SOLE |
| G52694109 | KNSA | KINIKSA PHARMACEUTICALS INTL | $919,761 | 0.17% | 41,412 | Common | SOLE |
| 03940C100 | ACLXGBX | ARCELLX INC | $915,907 | 0.17% | 13,962 | Common | SOLE |
| 75886F107 | REGN | REGENERON PHARMACEUTICALS | $863,187 | 0.16% | 1,361 | Common | SOLE |
| G52443101 | KVACU | KEEN VISION ACQUISITION CORP | $841,500 | 0.16% | 75,000 | Common | SOLE |
| 00847X104 | AGIO | AGIOS PHARMACEUTICALS INC | $817,470 | 0.15% | 27,900 | Common | SOLE |
| 00439U104 | GRCE | GRACE THERAPEUTICS INC | $783,207 | 0.15% | 343,512 | Common | SOLE |
| 49372L209 | 2KZ0 | KEZAR LIFE SCIENCES INC | $719,332 | 0.13% | 147,404 | Common | SOLE |
| 04280A100 | ARWR | ARROWHEAD PHARMACEUTICALS IN | $717,262 | 0.13% | 56,300 | Common | SOLE |
| 85205L107 | SWTXUSD | SPRINGWORKS THERAPEUTICS INC | $661,950 | 0.12% | 15,000 | CALL | SOLE |
| 86366E106 | GPCR | STRUCTURE THERAPEUTICS INC | $616,565 | 0.11% | 35,619 | Common | SOLE |
| 09062X103 | BIIB | BIOGEN INC | $615,780 | 0.11% | 4,500 | Common | SOLE |
| 46565G104 | 5E7 | ITEOS THERAPEUTICS INC | $603,543 | 0.11% | 101,096 | Common | SOLE |
| 632307104 | NTRA | NATERA INC | $600,992 | 0.11% | 4,250 | Common | SOLE |
| 98985Y108 | ZYME | ZYMEWORKS INC | $595,500 | 0.11% | 50,000 | Common | SOLE |
| 52886X107 | LXEO | LEXEO THERAPEUTICS INC | $591,455 | 0.11% | 170,448 | Common | SOLE |
| 49721T507 | KPRX | KIORA PHARMACEUTICALS INC | $585,942 | 0.11% | 194,665 | Common | SOLE |
| 84833T103 | SPRO | SPERO THERAPEUTICS INC | $576,919 | 0.11% | 801,277 | Common | SOLE |
| G1110E107 | BHVN | BIOHAVEN LTD | $544,290 | 0.10% | 22,641 | Common | SOLE |
| 74365U107 | TARA | PROTARA THERAPEUTICS INC | $522,659 | 0.10% | 122,690 | Common | SOLE |
| 97717Y527 | USFR | WISDOMTREE TR | $503,300 | 0.09% | 10,000 | Common | SOLE |
| G0131Y100 | ANSC | AGRICULTURE & NAT SOL ACQ CO | $502,062 | 0.09% | 47,062 | Common | SOLE |
| 532457108 | LLY | ELI LILLY & CO | $495,546 | 0.09% | 600 | Common | SOLE |
| 558868105 | MDGL | MADRIGAL PHARMACEUTICALS INC | $493,533 | 0.09% | 1,490 | Common | SOLE |
| 92243G108 | PCVX | VAXCYTE INC | $483,328 | 0.09% | 12,800 | Common | SOLE |
| 75989R107 | RNXT | RENOVORX INC | $475,084 | 0.09% | 479,883 | Common | SOLE |
| 014442107 | ALEC | ALECTOR INC | $467,806 | 0.09% | 380,330 | Common | SOLE |
| 457669307 | INSM | INSMED INC | $463,385 | 0.09% | 6,074 | Common | SOLE |
| 09075V102 | BNTX | BIONTECH SE | $455,300 | 0.08% | 5,000 | Common | SOLE |
| 171757206 | CDTX | CIDARA THERAPEUTICS INC | $451,005 | 0.08% | 20,938 | Common | SOLE |
| 88032L605 | TENX | TENAX THERAPEUTICS INC | $450,254 | 0.08% | 68,741 | Common | SOLE |
| 28036F105 | EWTX | EDGEWISE THERAPEUTICS INC | $440,000 | 0.08% | 20,000 | Common | SOLE |
| G6363K106 | — | NABORS ENERGY TRANSITION COR | $436,905 | 0.08% | 39,900 | Common | SOLE |
| 374163103 | GERN | GERON CORP | $423,220 | 0.08% | 266,176 | Common | SOLE |
| 45783C200 | TIL | INSTIL BIO INC | $422,334 | 0.08% | 24,328 | Common | SOLE |
| 483497103 | KALV | KALVISTA PHARMACEUTICALS INC | $412,474 | 0.08% | 35,743 | Common | SOLE |
| 03753U106 | APLSUSD | APELLIS PHARMACEUTICALS INC | $371,790 | 0.07% | 17,000 | Common | SOLE |
| 04016X101 | ARGX | ARGENX SE | $355,119 | 0.07% | 600 | Common | SOLE |
| 88427A107 | — | THIRD HARMONIC BIO INC | $347,000 | 0.06% | 100,000 | Common | SOLE |
| 46120E602 | ISRG | INTUITIVE SURGICAL INC | $346,689 | 0.06% | 700 | Common | SOLE |
| 09061G101 | BMRN | BIOMARIN PHARMACEUTICAL INC | $346,381 | 0.06% | 4,900 | Common | SOLE |
| 252828108 | DNTH | DIANTHUS THERAPEUTICS INC | $331,690 | 0.06% | 18,285 | Common | SOLE |
| 64135M105 | NGNE | NEUROGENE INC | $327,002 | 0.06% | 27,925 | Common | SOLE |
| G31249108 | ESTA | ESTABLISHMENT LABS HLDGS INC | $326,440 | 0.06% | 8,000 | Common | SOLE |
| 92332V107 | VTYXUSD | VENTYX BIOSCIENCES INC | $323,840 | 0.06% | 281,600 | Common | SOLE |
| G5212E105 | — | JVSPAC ACQUISITION CORP | $321,600 | 0.06% | 30,000 | Common | SOLE |
| 26818M108 | DYN | DYNE THERAPEUTICS INC | $314,836 | 0.06% | 30,099 | Common | SOLE |
| 68218J103 | OABI | OMNIAB INC | $302,659 | 0.06% | 126,108 | Common | SOLE |
| 655664100 | JWNUSD | NORDSTROM INC | $293,400 | 0.05% | 12,000 | Common | SOLE |
| 501575104 | KYMR | KYMERA THERAPEUTICS INC | $273,700 | 0.05% | 10,000 | Common | SOLE |
| 71722W107 | PHAT | PHATHOM PHARMACEUTICALS INC | $268,356 | 0.05% | 42,800 | Common | SOLE |
| 15117B202 | CLDX | CELLDEX THERAPEUTICS INC NEW | $264,990 | 0.05% | 14,600 | Common | SOLE |
| 462837105 | UCFI | IRON HORSE ACQUISITIONS CORP | $262,000 | 0.05% | 25,000 | Common | SOLE |
| 92915B106 | VYGR | VOYAGER THERAPEUTICS INC | $255,342 | 0.05% | 75,545 | Common | SOLE |
| 67080M103 | NRIX | NURIX THERAPEUTICS INC | $251,856 | 0.05% | 21,200 | Common | SOLE |
| 38341P102 | GOSS | GOSSAMER BIO INC | $249,951 | 0.05% | 227,228 | Common | SOLE |
| 88338N206 | TXMD | THERAPEUTICSMD INC | $249,898 | 0.05% | 270,160 | Common | SOLE |
| 00773J202 | SYRE | SPYRE THERAPEUTICS INC | $242,557 | 0.05% | 15,033 | Common | SOLE |
| 23954D109 | DAWNGBX | DAY ONE BIOPHARMACEUTICALS I | $222,222 | 0.04% | 28,023 | Common | SOLE |
| 04351P101 | ASNDUSD | ASCENDIS PHARMA A/S | $218,516 | 0.04% | 1,402 | Common | SOLE |
| M8001Q126 | PYPD | POLYPID LTD | $217,017 | 0.04% | 80,080 | Common | SOLE |
| 30063P105 | EXK | EXACT SCIENCES CORP | $216,450 | 0.04% | 5,000 | Common | SOLE |
| 21077P108 | CNTX | CONTEXT THERAPEUTICS INC | $214,870 | 0.04% | 351,094 | Common | SOLE |
| 61559X104 | MLTX | MOONLAKE IMMUNOTHERAPEUTICS | $211,916 | 0.04% | 5,424 | Common | SOLE |
| 86150R107 | STOK | STOKE THERAPEUTICS INC | $200,065 | 0.04% | 30,085 | Common | SOLE |
| G2283U100 | — | COLOMBIER ACQUISITION CORP I | $197,163 | 0.04% | 18,513 | Common | SOLE |
| 22053A107 | — | QUINCE THERAPEUTICS INC | $190,134 | 0.04% | 142,958 | Common | SOLE |
| 24823R105 | DNLI | DENALI THERAPEUTICS INC | $188,603 | 0.04% | 13,873 | Common | SOLE |
| Y95308105 | WVE | WAVE LIFE SCIENCES LTD | $186,648 | 0.03% | 23,100 | Common | SOLE |
| 09090D301 | — | BIOMX INC | $166,487 | 0.03% | 299,598 | Common | SOLE |
| 50127T109 | KURA | KURA ONCOLOGY INC | $165,000 | 0.03% | 25,000 | Common | SOLE |
| 00509G209 | ABOS | ACUMEN PHARMACEUTICALS INC | $160,801 | 0.03% | 146,183 | Common | SOLE |
| 68622V106 | OGN | ORGANON & CO | $148,900 | 0.03% | 10,000 | Common | SOLE |
| 28658R106 | CLYM | CLIMB BIO INC | $145,570 | 0.03% | 119,320 | Common | SOLE |
| 032797300 | AVXL | ANAVEX LIFE SCIENCES CORP | $139,176 | 0.03% | 16,221 | Common | SOLE |
| 45257U108 | IMNM | IMMUNOME INC | $134,600 | 0.02% | 20,000 | Common | SOLE |
| 83422E204 | SLDB | SOLID BIOSCIENCES INC | $127,572 | 0.02% | 34,479 | Common | SOLE |
| 85209E109 | — | SPRUCE BIOSCIENCES INC | $117,118 | 0.02% | 403,716 | Common | SOLE |
| 004468500 | ACHV | ACHIEVE LIFE SCIENCES INC | $115,272 | 0.02% | 43,173 | Common | SOLE |
| 92941V308 | VYNE | VYNE THERAPEUTICS INC | $111,262 | 0.02% | 70,419 | Common | SOLE |
| 69353Y103 | PMVP | PMV PHARMACEUTICALS INC | $110,099 | 0.02% | 101,008 | Common | SOLE |
| 29286M105 | — | ENGENE HOLDINGS INC | $106,620 | 0.02% | 23,799 | Common | SOLE |
| 015857105 | AQN | ALGONQUIN PWR UTILS CORP | $102,800 | 0.02% | 20,000 | Common | SOLE |
| G1933S101 | CASIF | CASI PHARMACEUTICALS INC | $102,427 | 0.02% | 47,420 | Common | SOLE |
| 18914F103 | CLOV | CLOVER HEALTH INVESTMENTS CO | $101,597 | 0.02% | 28,300 | Common | SOLE |
| 097702104 | BOLT1EUR | BOLT BIOTHERAPEUTICS INC | $97,986 | 0.02% | 244,966 | Common | SOLE |
| 82024L103 | STTK | SHATTUCK LABS INC | $97,058 | 0.02% | 102,156 | Common | SOLE |
| 91678A107 | UPB | UPSTREAM BIO INC | $91,800 | 0.02% | 15,000 | Common | SOLE |
| 05338F306 | AVTX | AVALO THERAPEUTICS INC | $80,100 | 0.01% | 10,000 | Common | SOLE |
| 45790W108 | — | INOZYME PHARMA INC | $79,897 | 0.01% | 87,799 | Common | SOLE |
| 75629V104 | RXRX | RECURSION PHARMACEUTICALS IN | $79,350 | 0.01% | 15,000 | Common | SOLE |
| 09058V103 | BCRX | BIOCRYST PHARMACEUTICALS INC | $75,000 | 0.01% | 10,000 | Common | SOLE |
| 55234L105 | LYRAGBP | LYRA THERAPEUTICS INC | $67,343 | 0.01% | 533,200 | Common | SOLE |
| 71722W107 | PHAT | PHATHOM PHARMACEUTICALS INC | $63,327 | 0.01% | 10,100 | CALL | SOLE |
| 00534B100 | ADGM | ADAGIO MED HLDGS INC | $61,782 | 0.01% | 76,757 | Common | SOLE |
| 65343E108 | NXTCEUR | NEXTCURE INC | $57,642 | 0.01% | 120,012 | Common | SOLE |
| 87583X109 | TNGX | TANGO THERAPEUTICS INC | $56,644 | 0.01% | 41,346 | Common | SOLE |
| 28617K101 | ELDN | ELEDON PHARMACEUTICALS INC | $56,274 | 0.01% | 16,600 | Common | SOLE |
| 82686Q101 | SLN | SILENCE THERAPEUTICS PLC | $52,573 | 0.01% | 18,643 | Common | SOLE |
| 462260100 | IOVA | IOVANCE BIOTHERAPEUTICS INC | $52,281 | 0.01% | 15,700 | Common | SOLE |
| 640268108 | NKTREUR | NEKTAR THERAPEUTICS | $46,073 | 0.01% | 67,754 | Common | SOLE |
| 68277Q105 | OKUR | ONKURE THERAPEUTICS INC | $43,000 | 0.01% | 10,000 | Common | SOLE |
| 690469101 | OVID | OVID THERAPEUTICS INC | $36,139 | 0.01% | 115,867 | Common | SOLE |
| 62459M206 | — | MOVANO INC | $35,037 | 0.01% | 19,146 | Common | SOLE |
| 52187K200 | CYPH | LEAP THERAPEUTICS INC | $33,866 | 0.01% | 111,000 | Common | SOLE |
| G1000R127 | — | AA MISSION ACQUISITION CORP | $33,589 | 0.01% | 505,099 | Common | SOLE |
| 23284F105 | CTMX | CYTOMX THERAPEUTICS INC | $29,905 | 0.01% | 47,036 | Common | SOLE |
| G0544A145 | ASPCR | A SPAC III ACQUISITION CORP | $29,799 | 0.01% | 215,000 | Common | SOLE |
| 98422T100 | — | XILIO THERAPEUTICS INC | $28,976 | 0.01% | 40,000 | Common | SOLE |
| 713317105 | PEPG | PEPGEN INC | $28,595 | 0.01% | 20,352 | Common | SOLE |
| N71542109 | PRQR | PROQR THRAPEUTICS N V | $27,124 | 0.01% | 20,394 | Common | SOLE |
| 640979100 | NMRA | NEUMORA THERAPEUTICS INC. | $26,108 | 0.00% | 26,108 | Common | SOLE |
| 589492107 | MREO | MEREO BIOPHARMA GROUP PLC | $22,500 | 0.00% | 10,000 | Common | SOLE |
| 15117F807 | CLRBUSD | CELLECTAR BIOSCIENCES INC | $12,684 | 0.00% | 40,228 | Common | SOLE |
| 75120L100 | — | RALLYBIO CORP | $8,770 | 0.00% | 13,400 | Common | SOLE |
| G5212E113 | — | JVSPAC ACQUISITION CORP | $8,400 | 0.00% | 30,000 | Common | SOLE |
| 462837121 | — | IRON HORSE ACQUISITIONS CORP | $7,500 | 0.00% | 25,000 | Common | SOLE |
| 207523101 | — | CONNECT BIOPHARMA HLDGS LTD | $5,665 | 0.00% | 10,300 | Common | SOLE |
| G3034H141 | EMCRF | EMBRACE CHANGE ACQUISITN COR | $2,366 | 0.00% | 13,144 | Common | SOLE |
| 462837113 | UCFIW | IRON HORSE ACQUISITIONS CORP | $800 | 0.00% | 25,000 | Common | SOLE |
| G3034H125 | EMCWF | EMBRACE CHANGE ACQUISITN COR | $695 | 0.00% | 18,000 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.